After Denmark, two European states suspend vaccine expected to come to Kosovo

Norway and Iceland have become the last two states to suspend the use of the company's vaccine “AstraZeneca”, as Denmark made that decision. The move comes after reports that the vaccine has caused coagulating blood and the suspicious death of a nurse in Austria. “This is a decision is warning”, said Geir Bukholm, [...]
“This is a decision is warning”, said Geir Bukholm, director of the Department for Prevention and Control at the Norwegian Public Health Institute. “We expect information to see if there is any connection between the vaccine and this case with coagulating blood”, he added.
Italy has also said it will suspend the use of the AstraZeneca dose group used in Austria. Austria suspended the use of this vaccine after the death of a woman in her 50 ' s. She died of coagulating blood that appeared 10 days after the vaccine.
Following Norway and Iceland's decision, it has reached eight European countries that have suspended the use of AstraZeneca vaccine. In addition to these countries, Austria, Luxembourg, Denmark, Estonia, Latvia, and Lithuania have made the same decision.
European drug regulator said that according to preliminary research, the vaccine group in Austria is unlikely to have been linked to the death of a 49-year-old nurse who received the AstraZeneca vaccine, writes The Guardian, broadcast The Express.
With this vaccine, which will be produced by the “Serum” in India, Kosovo is expected to be supplied, but it is not known when exactly the first doses will reach. These doses in Kosovo are expected to arrive as part of the COVAX programme.











